Skip to main content
. Author manuscript; available in PMC: 2021 Jan 1.
Published in final edited form as: Cell Calcium. 2019 Nov 12;85:102109. doi: 10.1016/j.ceca.2019.102109

Table 1.

Breast Cancer Prognosis Based on Receptor Subtype [11]

Breast Cancer Subtype Receptor Status Breast Cancer Cases Stage I 5-year survival Metastatic Median Survival
Estrogen Receptor and Progesterone Receptor Positive ER+/PR+ 70% ≥ 99 4–5 y
Human Epidermal Growth Factor 2 Receptor Positive HER2+ 15–20% ≥ 94 5 y
Triple Receptor Negative Breast Cancer TNBC 15% ≥ 85 10–13 months